Table 2.
Characteristics | Controlsprekidanje(n = 4) | ME/CFS Patientsprekidanje(n = 6) |
---|---|---|
FSCM | 22 ± 2.4 | 74.8 ± 15.5 *** |
FSCM Mental fatigue | 11.8 ± 2.1 | 37 ± 8.9 ** |
FSCM Physical fatigue | 10.3 ± 0.5 | 37.8 ± 7.2 *** |
SF-36 Physical functioning | 100 ± 0 | 34 ± 18.5 *** |
SF-36 Role limitations due to physical health | 100 ± 0 | 5 ± 11.2 *** |
SF-36 Role limitations due to emotional problems | 100 ± 0 | 100 ± 0 |
SF-36 Energy/fatigue | 75 ± 18 | 24 ± 30.1 * |
SF-36 Emotional well-being | 93 ± 6 | 62 ± 26 |
SF-36 Social functioning | 97 ± 6 | 35 ± 32.4 * |
SF-36 Pain | 91 ± 12 | 45 ± 20.2 ** |
SF-36 General health | 85 ± 23 | 25 ± 17.7 ** |
SF-36 Health change | 50 ± 0 | 55 ± 20.9 |
Compass-31 | 1.6 ± 1.3 | 35.5 ± 20.6 * |
Fatigue Scale of Motor and Cognitive function (FSMC) evaluates symptoms of fatigue by giving a total fatigue score severity as well as sub-scores of mental and motor fatigue [39]. The Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) evaluates health-related quality of life [40], and COMPASS-31 specified and quantifies symptoms and severity of autonomic dysfunction [41]. Data are represented as mean ± SD * p-value < 0.05, ** p-value < 0.01, *** p-value < 0.001.